These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1316409)

  • 1. Mycoplasma contamination in human leukemia cell lines. II. Elimination with various antibiotics.
    Uphoff CC; Gignac SM; Drexler HG
    J Immunol Methods; 1992 Apr; 149(1):55-62. PubMed ID: 1316409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril).
    Fleckenstein E; Uphoff CC; Drexler HG
    Leukemia; 1994 Aug; 8(8):1424-34. PubMed ID: 7520103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of ciprofloxacin and BM-Cyclin in mycoplasma decontamination.
    Somasundaram C; Nicklas W; Matzku S
    In Vitro Cell Dev Biol; 1992; 28A(11-12):708-10. PubMed ID: 1483961
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of mycoplasma contamination in a large panel of cell cultures.
    Drexler HG; Gignac SM; Hu ZB; Hopert A; Fleckenstein E; Voges M; Uphoff CC
    In Vitro Cell Dev Biol Anim; 1994 May; 30A(5):344-7. PubMed ID: 8069460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antibiotic eradication of mycoplasma infections from continuous cell lines.
    Uphoff CC; Drexler HG
    In Vitro Cell Dev Biol Anim; 2002 Feb; 38(2):86-9. PubMed ID: 11929000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elimination of mycoplasmas from cultured human cell lines utilizing a combination of two antibiotics, quinolone and a pleuromutilin derivative].
    Mikamo S; Shiroko Y; Hirose I; Sekiguchi M
    Hum Cell; 1990 Mar; 3(1):37-44. PubMed ID: 1964584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics.
    Uphoff CC; Meyer C; Drexler HG
    Leukemia; 2002 Feb; 16(2):284-8. PubMed ID: 11840296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mycoplasma-contaminated continuous cell lines with mycoplasma removal agent (MRA).
    Gignac SM; Uphoff CC; MacLeod RA; Steube K; Voges M; Drexler HG
    Leuk Res; 1992 Aug; 16(8):815-22. PubMed ID: 1326687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of mycoplasma from infected leukemia cell lines.
    Gignac SM; Brauer S; Häne B; Quentmeier H; Drexler HG
    Leukemia; 1991 Feb; 5(2):162-5. PubMed ID: 2020199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mollicutes contamination: a new strategy for an effective rescue of cancer cell lines.
    Mariotti E; D'Alessio F; Mirabelli P; Di Noto R; Fortunato G; Del Vecchio L
    Biologicals; 2012 Jan; 40(1):88-91. PubMed ID: 22078664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of mycoplasma-contaminated cell cultures.
    Harlin H; Gajewski TF
    Curr Protoc Cytom; 2008 Jan; Appendix 3():Appendix 3C. PubMed ID: 18770641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mycoplasma contamination in cell cultures with Plasmocin.
    Uphoff CC; Denkmann SA; Drexler HG
    J Biomed Biotechnol; 2012; 2012():267678. PubMed ID: 23091342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Mycoplasma hyosynoviae and M. hyorhinis to antimicrobial agents.
    Kobayashi H; Sonmez N; Morozumi T; Mitani K; Ito N; Shiono H; Yamamoto K
    J Vet Med Sci; 1996 Nov; 58(11):1107-11. PubMed ID: 8959659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapeutic studies with 81723 hfu (tiamulin), a new pleuromutilin derivative in experimental mycoplasma pneumonia in pigs].
    Schuller W; Laber G; Walzl H
    Dtsch Tierarztl Wochenschr; 1977 Sep; 84(9):345-9. PubMed ID: 336345
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic.
    Heilmann C; Jensen L; Jensen JS; Lundstrom K; Windsor D; Windsor H; Webster D
    J Infect; 2001 Nov; 43(4):234-8. PubMed ID: 11869060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of Plasmocin™ on various mammalian cell lines infected by mollicutes in comparison with commonly used antibiotics in cell culture: a local experience.
    Molla Kazemiha V; Azari S; Amanzadeh A; Bonakdar S; Shojaei Moghadam M; Habibi Anbouhi M; Maleki S; Ahmadi N; Mousavi T; Shokrgozar MA
    Cytotechnology; 2011 Dec; 63(6):609-20. PubMed ID: 21866311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case of 37 year-old female with encephalomyelitis due to mycoplasma pneumoniae].
    Narisumi T; Aoki T; Honnda M; Onishi S; Morooka K
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1369-71. PubMed ID: 9745287
    [No Abstract]   [Full Text] [Related]  

  • 18. A safe and efficient method for elimination of cell culture mycoplasmas using ciprofloxacin.
    Schmitt K; Däubener W; Bitter-Suermann D; Hadding U
    J Immunol Methods; 1988 Apr; 109(1):17-25. PubMed ID: 3282011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of mycoplasma contamination in leukemia-lymphoma cell lines.
    Uphoff CC; Drexler HG
    Hum Cell; 2001 Sep; 14(3):244-7. PubMed ID: 11774744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
    Deguchi T; Kikuchi M; Yasuda M; Ito S
    J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.